Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.
Mitani S, Kito Y, Hino K, Kawakami K, Izawa N, Hanamura F, Yamamoto Y, Shoji H, Komori A, Boku S, Tsuchihashi K, Kato K, Nonagase Y, Matsumoto T, Furuta M, Kawakami H. Mitani S, et al. Among authors: tsuchihashi k. Target Oncol. 2023 Sep;18(5):707-715. doi: 10.1007/s11523-023-00996-0. Epub 2023 Sep 5. Target Oncol. 2023. PMID: 37668815
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Tsuchihashi K, Kusaba H, Yamada Y, Okumura Y, Shimokawa H, Komoda M, Uchino K, Yoshihiro T, Tsuruta N, Hanamura F, Inadomi K, Ito M, Sagara K, Nakano M, Nio K, Arita S, Ariyama H, Kohashi K, Tominaga R, Oda Y, Akashi K, Baba E. Tsuchihashi K, et al. Mol Clin Oncol. 2017 May;6(5):665-668. doi: 10.3892/mco.2017.1197. Epub 2017 Mar 17. Mol Clin Oncol. 2017. PMID: 28515919 Free PMC article.
Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report.
Yoshihiro T, Nio K, Tsuchihashi K, Ariyama H, Kohashi K, Tsuruta N, Hanamura F, Inadomi K, Ito M, Sagara K, Okumura Y, Nakano M, Arita S, Kusaba H, Oda Y, Akashi K, Baba E. Yoshihiro T, et al. Among authors: tsuchihashi k. Mol Clin Oncol. 2017 Jun;6(6):866-870. doi: 10.3892/mco.2017.1240. Epub 2017 May 5. Mol Clin Oncol. 2017. PMID: 28588779 Free PMC article.
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Yamaguchi K, Mishima K, Ohmura H, Hanamura F, Ito M, Nakano M, Tsuchihashi K, Ota SI, Wada N, Uchi H, Ariyama H, Kusaba H, Niiro H, Akashi K, Baba E. Yamaguchi K, et al. Among authors: tsuchihashi k. Cancer Sci. 2018 Oct;109(10):3032-3042. doi: 10.1111/cas.13758. Epub 2018 Aug 31. Cancer Sci. 2018. PMID: 30066977 Free PMC article. Clinical Trial.
Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer.
Nakano M, Ito M, Tanaka R, Ariyama H, Mitsugi K, Makiyama A, Uchino K, Esaki T, Tsuruta N, Hanamura F, Yamaguchi K, Okumura Y, Sagara K, Takayoshi K, Nio K, Tsuchihashi K, Tamura S, Shimokawa H, Arita S, Miyawaki K, Kusaba H, Akashi K, Baba E. Nakano M, et al. Among authors: tsuchihashi k. Cancer Sci. 2018 Nov;109(11):3461-3470. doi: 10.1111/cas.13777. Epub 2018 Sep 27. Cancer Sci. 2018. PMID: 30142697 Free PMC article.
PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer.
Nakano M, Ito M, Tanaka R, Yamaguchi K, Ariyama H, Mitsugi K, Yoshihiro T, Ohmura H, Tsuruta N, Hanamura F, Sagara K, Okumura Y, Nio K, Tsuchihashi K, Arita S, Kusaba H, Akashi K, Baba E. Nakano M, et al. Among authors: tsuchihashi k. Cancer Sci. 2018 Sep;109(9):2986-2992. doi: 10.1111/cas.13723. Cancer Sci. 2018. PMID: 30187676 Free PMC article.
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.
Yoshihiro T, Kusaba H, Makiyama A, Kobayashi K, Uenomachi M, Ito M, Doi Y, Mitsugi K, Aikawa T, Takayoshi K, Esaki T, Shimokawa H, Tsuchihashi K, Ariyama H, Akashi K, Baba E. Yoshihiro T, et al. Among authors: tsuchihashi k. Int J Clin Oncol. 2019 May;24(5):508-515. doi: 10.1007/s10147-018-01391-w. Epub 2019 Jan 2. Int J Clin Oncol. 2019. PMID: 30604155 Clinical Trial.
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
Moriwaki T, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Oki E, Komatsu Y, Tsuji A, Tsuchihashi K, Sakai D, Ueno H, Tamura T, Yamashita K, Shimada Y. Moriwaki T, et al. Among authors: tsuchihashi k. Int J Clin Oncol. 2020 Apr;25(4):614-621. doi: 10.1007/s10147-019-01600-0. Epub 2019 Dec 14. Int J Clin Oncol. 2020. PMID: 31838590
Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer.
Yamaguchi K, Ito M, Ohmura H, Hanamura F, Nakano M, Tsuchihashi K, Nagai S, Ariyama H, Kusaba H, Yamamoto H, Oda Y, Nakamura M, Akashi K, Baba E. Yamaguchi K, et al. Among authors: tsuchihashi k. Oncoimmunology. 2020 Feb 17;9(1):1724763. doi: 10.1080/2162402X.2020.1724763. eCollection 2020. Oncoimmunology. 2020. PMID: 32117589 Free PMC article.
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
Ohmura H, Yamaguchi K, Hanamura F, Ito M, Makiyama A, Uchino K, Shimokawa H, Tamura S, Esaki T, Mitsugi K, Shibata Y, Oda H, Tsuchihashi K, Ariyama H, Kusaba H, Oda Y, Akashi K, Baba E. Ohmura H, et al. Among authors: tsuchihashi k. Br J Cancer. 2020 May;122(10):1507-1517. doi: 10.1038/s41416-020-0810-1. Epub 2020 Mar 23. Br J Cancer. 2020. PMID: 32203221 Free PMC article.
315 results